Acquisitions and other Investments - schedule of purchase price allocation and identifiable assets acquired and liabilities assumed - Shields (Details) - USD ($) $ in Millions |
Oct. 29, 2021 |
Aug. 31, 2024 |
Aug. 31, 2023 |
Aug. 31, 2022 |
|---|---|---|---|---|
| Identifiable assets acquired and liabilities assumed: | ||||
| Goodwill | $ 15,506 | $ 28,187 | $ 22,280 | |
| Shields Health Solutions | ||||
| Purchase price allocation: | ||||
| Cash consideration | $ 969 | |||
| Fair value of equity consideration | 13 | |||
| Fair value of previously held equity and debt | 502 | |||
| Fair value of non-controlling interest | 589 | |||
| Total | 2,074 | |||
| Identifiable assets acquired and liabilities assumed: | ||||
| Tangible assets | 84 | |||
| Intangible assets | 1,060 | |||
| Liabilities | (600) | |||
| Total identifiable net assets | 544 | |||
| Goodwill | $ 1,529 |
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to, instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Lived Tangible Assets No definition available.
|
| X | ||||||||||
- Definition Business Combination, Step Acquisition, Noncontrolling Interest in Acquiree, Fair Value No definition available.
|
| X | ||||||||||
- Details
|